A Prospective, Non-Controlled Study of Quality of Life and Symptoms Perception Using HM-PRO Tool as a Patient-Reported Outcome Measurement (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy. (October 2022)